Literature DB >> 1713197

Molecular conservation of the P6 outer membrane protein among strains of Haemophilus influenzae: analysis of antigenic determinants, gene sequences, and restriction fragment length polymorphisms.

M B Nelson1, R S Munson, M A Apicella, D J Sikkema, J P Molleston, T F Murphy.   

Abstract

Infections caused by Haemophilus influenzae are a major worldwide health problem. In particular, nontypeable strains of H. influenzae are a common cause of otitis media in infants and children. A vaccine to prevent these infections would result in the prevention of substantial morbidity and cost savings. A problem in identifying an appropriate vaccine antigen has been the enormous antigenic heterogeneity among nontypeable strains of H. influenzae. The present study was undertaken to characterize the conservation of the P6 outer membrane protein (approximately 16,000 daltons) among strains of H. influenzae. A total of 20 type b strains and 20 nontypeable strains of diverse geographic and clinical origins was studied. Three approaches were taken. (i) Antigenic determinants recognized by monoclonal and polyclonal antibodies were present on P6 in all 40 strains tested. The molecular weight of P6 was identical in all strains. (ii) Comparison of the DNA sequences of the P6 genes from three epidemiologically and serologically unrelated strains demonstrated 100% homology at the amino acid level and 97 to 99% homology at the nucleotide level. (iii) Restriction fragment length polymorphism analysis demonstrated that the P6 gene and flanking sequences were highly conserved among all strains. These three independent series of experiments indicated that the P6 protein is highly conserved among strains of H. influenzae. P6 should receive serious consideration for inclusion in a vaccine to prevent infections caused by nontypeable H. influenzae.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713197      PMCID: PMC258070          DOI: 10.1128/iai.59.8.2658-2663.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Acute epiglottitis in childhood; a serious emergency, readily recognized at the bedside.

Authors:  W BERENBERG; S KEVY
Journal:  N Engl J Med       Date:  1958-05-01       Impact factor: 91.245

2.  Cloning of genes encoding a 15,000-dalton peptidoglycan-associated outer membrane lipoprotein and an antigenically related 15,000-dalton protein from Haemophilus influenzae.

Authors:  R A Deich; B J Metcalf; C W Finn; J E Farley; B A Green
Journal:  J Bacteriol       Date:  1988-02       Impact factor: 3.490

3.  Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants.

Authors:  A A Lenoir; P D Granoff; D M Granoff
Journal:  Pediatrics       Date:  1987-08       Impact factor: 7.124

Review 4.  Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease.

Authors:  G A Weinberg; D M Granoff
Journal:  J Pediatr       Date:  1988-10       Impact factor: 4.406

5.  Purification, cloning, and sequence of outer membrane protein P1 of Haemophilus influenzae type b.

Authors:  R Munson; S Grass
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  Purification and characterization of a peptidoglycan-associated lipoprotein from Haemophilus influenzae.

Authors:  G W Zlotnick; V T Sanfilippo; J A Mattler; D H Kirkley; R A Boykins; R C Seid
Journal:  J Biol Chem       Date:  1988-07-15       Impact factor: 5.157

7.  Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.

Authors:  G A Weinberg; M S Einhorn; A A Lenoir; P D Granoff; D M Granoff
Journal:  J Pediatr       Date:  1987-07       Impact factor: 4.406

8.  Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant.

Authors:  P W Anderson; M E Pichichero; R A Insel; R Betts; R Eby; D H Smith
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

9.  Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae.

Authors:  D M Musher; K R Kubitschek; J Crennan; R E Baughn
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

10.  Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein.

Authors:  M S Einhorn; G A Weinberg; E L Anderson; P D Granoff; D M Granoff
Journal:  Lancet       Date:  1986-08-09       Impact factor: 79.321

View more
  33 in total

1.  Neonatal, urogenital isolates of biotype 4 nontypeable Haemophilus influenzae express a variant P6 outer membrane protein molecule.

Authors:  T F Murphy; C Kirkham; D J Sikkema
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Haemophilus influenzae vaccine candidate outer membrane protein P6 is not conserved in all strains.

Authors:  Arthur Chang; Ravinder Kaur; Lea Vacca Michel; Janet R Casey; Michael Pichichero
Journal:  Hum Vaccin       Date:  2011-01-01

3.  Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells.

Authors:  T Shuto; H Xu; B Wang; J Han; H Kai; X X Gu; T F Murphy; D J Lim; J D Li
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 4.  Antigenic diversity and gene polymorphisms in Haemophilus influenzae.

Authors:  J R Gilsdorf
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

5.  Potential of a novel protein, OMP26, from nontypeable Haemophilus influenzae to enhance pulmonary clearance in a rat model.

Authors:  J M Kyd; A W Cripps
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

6.  Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children.

Authors:  Ravinder Kaur; Janet R Casey; Michael E Pichichero
Journal:  Vaccine       Date:  2010-12-01       Impact factor: 3.641

7.  Mapping of a surface-exposed, conformational epitope of the P6 protein of Haemophilus influenzae.

Authors:  J A Bogdan; M A Apicella
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Conservation of immune responses to proteins isolated by preparative polyacrylamide gel electrophoresis from the outer membrane of nontypeable Haemophilus influenzae.

Authors:  J M Kyd; D Taylor; A W Cripps
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Protein D, a putative immunoglobulin D-binding protein produced by Haemophilus influenzae, is glycerophosphodiester phosphodiesterase.

Authors:  R S Munson; K Sasaki
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

10.  Molecular analysis of the P2 porin protein of nontypeable Haemophilus influenzae.

Authors:  D J Sikkema; T F Murphy
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.